Structured evidence table for Fucoxanthin Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Fucoxanthin Blood Pressure Randomized Trial | As a result, T2D has emerged as a major global health challenge, affecting hundreds of millions of individuals and imposing substantial clinical and economic burdens worldwide. | 3 | Jung Un Ju (2026) | Brown Seaweeds and Their Bioactive Compounds in Type 2 Diabetes: Mechanisms Underlying Metabolic Regulation |
| Fucoxanthin Blood Pressure Randomized Trial | 4 4 5 6 7 Traditionally, T2D management has focused primarily on achieving glycemic control to prevent hyperglycemia-driven microvascular complications, such as retinopathy and neuropathy, alongside the management of macrovascular risk, including cardiovascular disease (CVD) []. | 3 | Jung Un Ju (2026) | Brown Seaweeds and Their Bioactive Compounds in Type 2 Diabetes: Mechanisms Underlying Metabolic Regulation |
| Fucoxanthin Blood Pressure Randomized Trial | However, current therapeutic strategies increasingly adopt a multifactorial approach that integrates glycemic control with the management of body weight, cardiovascular risk factors, comorbidities, and diabetes-related complications []. | 3 | Jung Un Ju (2026) | Brown Seaweeds and Their Bioactive Compounds in Type 2 Diabetes: Mechanisms Underlying Metabolic Regulation |
| Fucoxanthin Blood Pressure Randomized Trial | 1 2 3 Type 2 diabetes (T2D) is a complex and progressive metabolic disease characterized by chronic hyperglycemia resulting from insulin resistance, impaired insulin secretion, and dysregulated glucose homeostasis across multiple organs, including the liver, skeletal muscle, adipose tissue, and intestine []. | 3 | Jung Un Ju (2026) | Brown Seaweeds and Their Bioactive Compounds in Type 2 Diabetes: Mechanisms Underlying Metabolic Regulation |
| Fucoxanthin Blood Pressure Randomized Trial | 1 2 3 4 Algae have long played an important role in human nutrition and traditional medicine, with archaeological evidence indicating their use as early as 14,000 years ago (). | 4 | Can Basak (2026) | Secret heroes of the sea: brown macroalgae and their bioactive powers—a narrative review |
| Fucoxanthin Blood Pressure Randomized Trial | Previous studies have reported a range of biological activities associated with algal-derived compounds, including antioxidant, anti-inflammatory, antiviral, and metabolic regulatory effects (). | 4 | Can Basak (2026) | Secret heroes of the sea: brown macroalgae and their bioactive powers—a narrative review |
| Fucoxanthin Blood Pressure Randomized Trial | However, much of the existing evidence is derived fromand experimental models, which limits the translation of these findings to human health applications. | 4 | Can Basak (2026) | Secret heroes of the sea: brown macroalgae and their bioactive powers—a narrative review |
| Fucoxanthin Blood Pressure Randomized Trial | They represent a highly diverse group of photosynthetic organisms adapted to a wide range of aquatic and semi-aquatic environments (,). | 4 | Can Basak (2026) | Secret heroes of the sea: brown macroalgae and their bioactive powers—a narrative review |
Source documents